Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Supreme Court May Consider Ruling Invalidating Amgen’s Repatha Patents

Apr 20 2022

• By Brenda Sandburg

US Supreme Court — US Supreme Court may hear Amgen's PCSK9 patent dispute with Sanofi • Source: Alamy

Related Content

After Two Jury Verdicts, Court Finds Repatha Patents Invalid

Aug 29 2019

Amgen’s Growth Story Relies Mainly On Continuing Plot Lines

Feb 09 2022

Related Companies

Amgen, Inc.

Sanofi

GSK plc

Biogen, Inc.

Bristol Myers Squibb Company

Additional Topics

United States Intellectual Property Legal Issues Policy BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.